Author:
Patsatzis Dimitris G.,Wu Shengjia,Shah Dhaval K.,Goussis Dimitris A.
Abstract
AbstractA demonstration is provided on how algorithmic asymptotic analysis of multi-scale pharmacokinetics (PK) systems can provide (1) system level understanding and (2) predictions on the response of the model when parameters vary. Being algorithmic, this type of analysis is not hindered by the size or complexity of the model and requires no input from the investigator. The algorithm identifies the constraints that are generated by the fast part of the model and the components of the slow part of the model that drive the system within these constraints. The demonstration is based on a typical monoclonal antibody PK model. It is shown that the findings produced by the traditional methodologies, which require significant input by the investigator, can be produced algorithmically and more accurately. Moreover, additional insights are provided by the algorithm, which cannot be obtained by the traditional methodologies; notably, the dual influence of certain reactions depending on whether their fast or slow component dominates. The analysis reveals that the importance of physiological processes in determining the systemic exposure of monoclonal antibodies (mAb) varies with time. The analysis also confirms that the rate of mAb uptake by the cells, the binding affinity of mAb to neonatal Fc receptor (FcRn), and the intracellular degradation rate of mAb are the most sensitive parameters in determining systemic exposure of mAbs. The algorithmic framework for analysis introduced and the resulting novel insights can be used to engineer antibodies with desired PK properties.
Funder
Khalifa University of Science, Technology and Research
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Sorger, P. K. et al. Quantitative and Systems Pharmacology in the Post-Genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic Mechanisms. in An NIH White Paper by the QSP Workshop Group, vol. 48, 1–47 (NIH Bethesda Bethesda, MD, 2011).
2. Snowden, T. J., van der Graaf, P. H. & Tindall, M. J. Model reduction in mathematical pharmacology. J. Pharmacokinet. Pharmacodyn. 45, 537–555. https://doi.org/10.1007/s10928-018-9584-y (2018).
3. Hasegawa, C. & Duffull, S. B. Selection and qualification of simplified QSP models when using model order reduction techniques. AAPS J. 20, 1–11. https://doi.org/10.1208/s12248-017-0170-9 (2018).
4. Strutz, J., Martin, J., Greene, J., Broadbelt, L. & Tyo, K. Metabolic kinetic modeling provides insight into complex biological questions, but hurdles remain. Curr. Opin. Biotechnol. 59, 24–30. https://doi.org/10.1016/j.copbio.2019.02.005 (2019).
5. Gibiansky, L. & Gibiansky, E. Target-mediated drug disposition model: Approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics. Exp. Opin. Drug Metab. Toxicol. 5, 803–812. https://doi.org/10.1517/17425250902992901 (2009).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献